JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. / Fundamentals
Income statement
- Net revenue
€25.23M - Cost of goods sold
€14.96M - Gross profit
€10.27M - SG&A expenses
€6.93M - R&D expenses
€0.00 - EBITDA
€2.05M - D&A
€1.77M - EBIT
€3.55M - Interest expenses
€408.03K - EBT
-€117.85K - Tax expenses
€200.34K - Net income
€746.78K
Cash flow statement
- Net deferred tax
€200.32K - Non-cash items
€2.87M - Changes in working capital
-€1.17M - Operating cash flow
€3.35M - Capex
€1.18M - Other investing cash flow
€10.97K - Net investing cash flow
-€1.15M - Total cash dividends paid
-€393.87K - Issuance of common stock
€1.31K - Debt repayment
-€1.23M - Other financing cash flow
-€444.86K - Net financing cash flow
-€2.07M - Foreign exchange effects
€0.00 - Net change in cash
€126.33K - Cash at end of period
€977.78K - Free cash flow
€4.53M
Balance sheet
- Cash and cash equivalents
€977.78K - Cash and short-term investments
€977.78K - Total receivables
€4.63M - Inventory
€3.56M - Other current assets
€3.94K - Total current assets
€9.17M - Property, plant & equipment
€23.24M - Goodwill
€855.01K - Intangible assets
€128.68K - Long-term investments
€438.37K - Other non-current assets
€127.84K - Total non-current assets
€26.11M - Total assets
€35.28M - Accounts payable
€1.74M - Short-term debt
€2.22M - Other current liabilities
€1.20M - Total current liabilities
€5.97M - Long-term debt
€4.57M - Deferred tax liabilities
€5.23K - Other non-current liabilities
€497.18K - Total non-current liabilities
€5.34M - Total liabilities
€11.31M - Common stock
€6.23M - Retained earnings
€1.67M - Other equity
€0.00 - Total equity
€23.98M - Total liabilities and shareholders' equity
€35.28M
Company information
- Market capitalization
€20.76M - Employees
0 - Enterprise Value
€1.10B
Company ratios
- Gross margin
-
40.7% Better than peer group: 31.7% - EBITDA margin
-
8.1% Worse than peer group: 21.5% - EBIT margin
-
14.1% Even with peer group: 16.0% - EBT margin
-
-0.5% Worse than peer group: 14.8% - Net margin
-
3.0% Worse than peer group: 11.7% - ROE
-
3.1% Worse than peer group: 8.7% - ROA
-
2.1% Even with peer group: 5.1% - Asset turnover
-
71.5% Worse than peer group: 86.0% - FCF margin
-
8.6% Much better than peer group: -18.0% - FCF yield
10.5% - Efficiency ratio
91.9% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00